Keywords: roche, licenses, sankyo, cs-023, swiss, drugs, diagnostics

Roche licenses Sankyo's CS-023

Article | 17 November 2003

Swiss drugs and diagnostics major Roche has acquired the exclusiverights to Japan-based Sankyo's CS-023. The agent, a parenteral carbapenem antibiotic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Sankyo

Go to company listing